-
Mylan acquires Abbott’s developed markets specialty & branded generics biz
Mylan has entered into a definitive agreement with Abbott whereby Mylan will acquire Abbott's non-U.S. developed markets specialty and branded generics business in an all-stock transaction.
Upon closing, Abbott will receive 105 million shares of the combined company worth approximately $5.3 billion based on Mylan's closing price of $50.20 on Friday, July 11, 2014, representing an approximately 21% ownership stake.
-
This Is retail: Filling the Gap
Three women from Gap’s different brands highlight how they got started in retail, stayed engaged with the business and achieved personal growth in the most recent installment of “This Is Retail” from the National Retail Federation.
Click here to hear from Attica Jacques, Andrea Shimer and Kendra Maleiro began their careers began and what they are doing now.